TENET HEALTHCARE CORP
For the period ended Mar 31, 2024. Filed Apr 30, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed Apr 30, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Cover page
Show cover page
| UNITED STATES | |
|---|---|
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, DC 20549 | |
| Form 10-Q | |
| ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2024 | |
| OR | |
| ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to | |
| Commission File Number: 1-7293 | |
| TENET HEALTHCARE CORPORATION | |
| (Exact name of Registrant as specified in its charter) | |
| Nevada(State of Incorporation) | 95-2557091(IRS Employer Identification No.) |
| 14201 Dallas Parkway Dallas, TX 75254(Address of principal executive offices, including zip code) | |
| (469) 893-2200 (Registrant’s telephone number, including area code) | |
| Securities registered pursuant to Section 12(b) of the Act: | |
| Title of each class | Trading symbol | Name of each exchange on which registered |
| Common stock, $0.05 par value | THC | New York Stock Exchange |
| 6.875% Senior Notes due 2031 | THC31 | New York Stock Exchange |
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ¨
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months. Yes ý No ¨
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company (each as defined in Exchange Act Rule 12b-2).
| Large accelerated filer ý | Accelerated filer ¨ | Non-accelerated filer ¨ |
|---|
| Smaller reporting company ¨ | Emerging growth company ¨ |
|---|
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the Registrant is a shell company (as defined in Exchange Act Rule 12b-2). Yes ¨ No ý
As of April 26, 2024, there were 97,683 shares (in thousands) of the Registrant’s common stock outstanding.
TENET HEALTHCARE CORPORATION
TABLE OF CONTENTS
| Page | ||
|---|---|---|
| PART I. FINANCIAL INFORMATION | ||
| Item 1. · Financial Statements (Unaudited) | ||
| Condensed Consolidated Financial Statements | 1 | |
| Notes to Condensed Consolidated Financial Statements | 5 | |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 23 |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 48 |
| Item 4. | Controls and Procedures | 48 |
| PART II. OTHER INFORMATION | ||
| Item 1. | Legal Proceedings | 49 |
| Item 1A. | Risk Factors | 49 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 49 |
| Item 5. | Other Information | 49 |
| Item 6. | Exhibits | 50 |
i
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.